Update on toxic myopathies

被引:0
|
作者
Fürer, V [1 ]
Reichmann, H [1 ]
机构
[1] Tech Univ Dresden, Klin & Poliklin Neurol, Klinikum Carl Gustav Carus, D-01307 Dresden, Germany
关键词
myopathy; mechanisms; alcohol; corticosteroids; lipid lowering agents; antiretroviral therapy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A growing number of drugs and toxins can cause functional and structural damage to human skeletal muscle. These myopathies may manifest themselves as an asymptomatic creatinin kinase elevation, muscle pain of weakness and even acute rhabdomyolysis. Early diagnosis is important, because these myopathies are potentially reversible on removal of the offending agent. The precise mechanisms remain mostly unclear. Main source of a toxic myopathy is chronic alcohol abuse. Drug-induced myopathies ore most frequently seen due to lipid lowering agents and corticosteroids. Since introduction of specific HIV-therapy antiretroviral substances gain importance as another trigger for myopathy.
引用
收藏
页码:264 / +
页数:6
相关论文
共 50 条
  • [31] Update on diagnostics of metabolic myopathies
    Toscano, Antonio
    Barca, Emanuele
    Musumeci, Olimpia
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (05) : 553 - 562
  • [32] Update diagnostic algorithm for myopathies
    Schoser, Benedikt
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (09) : 532 - 534
  • [33] Inflammatory myopathies: an update for neurologists
    Serafim Silva, Andre Macedo
    Campos, Eliene Dutra
    Zanoteli, Edmar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 238 - 248
  • [34] Update on Congenital Myopathies in Adulthood
    Papadimas, George Konstantinos
    Xirou, Sophia
    Kararizou, Evangelia
    Papadopoulos, Constantinos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [35] Update on idiopathic inflammatory myopathies
    Briani, C.
    Doria, A.
    Sarzi-Puttini, P.
    Dalakas, M. C.
    AUTOIMMUNITY, 2006, 39 (03) : 161 - 170
  • [36] Protein aggregate myopathies, a subgroup in congenital myopathies - an update and review
    Goebel, HH
    Goldfarb, L
    Laing, N
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 616 - 616
  • [37] Drug-induced and toxic myopathies
    Guis, S
    Mattéi, JP
    Lioté, F
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (06): : 877 - 907
  • [38] Toxic myopathies - Muscle biopsy features
    Scola, Rosana Herminia
    Pereira, Eduardo Rafael
    Lorenzoni, Paulo Jose
    Werneck, Lineu Cesar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (01) : 82 - 86
  • [39] Toxic and drug-induced myopathies
    Dalakas, M. C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (08): : 832 - 838
  • [40] Clinical and pathological aspects of toxic myopathies
    Le Quang, Megane
    Sole, Guilhem
    Martin-Negrier, Marie-Laure
    Mathis, Stephane
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 4864 - 4864